101 related articles for article (PubMed ID: 7668939)
1. Expression of c-erb B-2 protein and DNA ploidy in breast carcinogenesis.
Schmitt FC; Figueiredo P; Lacerda M
Arch Pathol Lab Med; 1995 Sep; 119(9):815-20. PubMed ID: 7668939
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
3. p53 protein expression and nuclear DNA content in breast intraductal proliferations.
Schmitt FC; Leal C; Lopes C
J Pathol; 1995 Jul; 176(3):233-41. PubMed ID: 7674086
[TBL] [Abstract][Full Text] [Related]
4. Intraductal spread of invasive breast carcinoma has a positive correlation with c-erb B-2 overexpression and vascular invasion.
Jing X; Kakudo K; Murakami M; Nakamura Y; Nakamura M; Yokoi T; Yang Q; Oura S; Sakurai T
Cancer; 1999 Aug; 86(3):439-48. PubMed ID: 10430252
[TBL] [Abstract][Full Text] [Related]
5. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical c-erbB-2 protooncogene expression and nuclear DNA content in human mammary carcinoma in situ.
Schimmelpenning H; Eriksson ET; Pallis L; Skoog L; Cedermark B; Auer GU
Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S48-52. PubMed ID: 1374218
[TBL] [Abstract][Full Text] [Related]
7. Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2.
Dabbs DJ
Mod Pathol; 1995 Aug; 8(6):637-42. PubMed ID: 8532697
[TBL] [Abstract][Full Text] [Related]
8. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
[TBL] [Abstract][Full Text] [Related]
9. HER-2/neu oncogene expression and DNA ploidy analysis in breast cancer.
Bacus SS; Bacus JW; Slamon DJ; Press MF
Arch Pathol Lab Med; 1990 Feb; 114(2):164-9. PubMed ID: 1967930
[TBL] [Abstract][Full Text] [Related]
10. C-erbB-2 protein and neuroendocrine expression in intraductal carcinomas of the breast.
Lilleng R; Hagmar BM; Nesland JM
Mod Pathol; 1992 Jan; 5(1):41-7. PubMed ID: 1347423
[TBL] [Abstract][Full Text] [Related]
11. Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas.
Zhang GJ; Kimijima I; Abe R; Kanno M; Katagata N; Hara K; Watanabe T; Tsuchiya A
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2329-35. PubMed ID: 9815631
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical demonstration of c-erb B-2 oncoprotein expression in female breast cancer and its prognostic significance.
Tervahauta A; Eskelinen M; Syrjänen S; Lipponen P; Pajarinen P; Syrjänen K
Anticancer Res; 1991; 11(5):1677-81. PubMed ID: 1685075
[TBL] [Abstract][Full Text] [Related]
13. Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast.
Crissman JD; Visscher DW; Kubus J
Arch Pathol Lab Med; 1990 Dec; 114(12):1249-53. PubMed ID: 2174672
[TBL] [Abstract][Full Text] [Related]
14. [Expression of the c-erbB-2 oncoprotein in mammary Paget's disease. Immunohistochemical study by using 3 antibodies].
Edorh A; Parache RM; Migeon C; N'Sossani B; Rihn B
Pathol Biol (Paris); 1995 Sep; 43(7):584-9. PubMed ID: 8570262
[TBL] [Abstract][Full Text] [Related]
15. Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: a study in Greek patients.
Gorgoulis VG; Barbatis C; Poulias I; Karameris AM
Mod Pathol; 1995 Sep; 8(7):758-64. PubMed ID: 8539234
[TBL] [Abstract][Full Text] [Related]
16. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
Latta EK; Tjan S; Parkes RK; O'Malley FP
Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
[TBL] [Abstract][Full Text] [Related]
17. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M
Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry.
Stål O; Sullivan S; Sun XF; Wingren S; Nordenskjöld B
Cytometry; 1994 Jun; 16(2):160-8. PubMed ID: 7924685
[TBL] [Abstract][Full Text] [Related]
19. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.
Wärnberg F; Nordgren H; Bergkvist L; Holmberg L
Br J Cancer; 2001 Sep; 85(6):869-74. PubMed ID: 11556839
[TBL] [Abstract][Full Text] [Related]
20. Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.
Heintz NH; Leslie KO; Rogers LA; Howard PL
Arch Pathol Lab Med; 1990 Feb; 114(2):160-3. PubMed ID: 1967929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]